A recent study published in Life Metabolism by researchers from the Affiliated Hospital of Nantong University has identified ...

Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, ...

Liver fibrosis, a progressive scarring of the liver tissue, represents a major global health burden with limited treatment ...

In combination, two commonly used heart drugs reverse fat accumulation in the liver, a study in animals has shown.

Across the world, more than 1.5 billion people suffer from chronic liver disease. The U.S. Centers for Disease Control and ...

A new study suggests a combination of cardiovascular drugs, pemafibrate and telmisartan, may reverse fatty liver disease by ...

Highly-Specific Allosteric ACLY Inhibitor Designed to Target Liver and Bile Duct Injury, Inflammation, and Fibrosis Associated with Primary ...

Once almost exclusively seen in older adults, fatty liver disease, which can be fatal if untreated, is now one of the world’s ...

“Drinking coffee regularly may lower the risk of liver disease; however, it should not be the only method you use to protect ...

HistoIndex, a pioneering leader in digital pathology solutions for chronic liver disease, is returning to The Liver Meeting® (TLM) 2025, hosted by the American Association for the Study of Liver ...